FDA Inspection 1039417 — ENESTIA BELGIUM NV (SHARP BELGIUM)
The FDA completed an inspection of ENESTIA BELGIUM NV (SHARP BELGIUM) on Dec 15, 2017 in Hamont-Achel. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 15, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Hamont-Achel (Belgium)